Literature DB >> 21776790

Tumor volume measurement errors of RECIST studied with ellipsoids.

Zachary H Levine1, Benjamin R Galloway, Adele P Peskin, Claus P Heussel, Joseph J Chen.   

Abstract

PURPOSE: The authors investigate the extent to which Response Evaluation Criteria in Solid Tumors (RECIST) can predict tumor volumes in ideal geometric settings and using clinical data.
METHODS: The authors consider a hierarchy of models including uniaxial ellipsoids, general ellipsoids, and composites of ellipsoids, using both analytical and numerical techniques to show how well RECIST can predict tumor volumes in each case. The models have certain features that are compared to clinical data.
RESULTS: The principal conclusion is that a change in the reported RECIST value needs to be a factor of at least 1.2 to achieve a 95% confidence that one ellipsoid is larger than another assuming the ratio of maximum to minimum diameters is no more than 2, an assumption that is reasonable for some classes of tumors. There is a significant probability that RECIST will select a tumor other than the largest due to orientation effects of nonspherical tumors: in previously reported malignoma data, RECIST would have selected a tumor other than the largest in 9% of the cases. Also, the widely used spherical model connecting RECIST values for a single tumor to volumes overestimates these volumes.
CONCLUSIONS: RECIST imposes a limit on the ability to determine tumor volumes, which is greater than the limit imposed by modem medical computed tomography machines. It is also likely the RECIST limit is above natural biological variability of stable lesions. The authors recommend the study of such natural variability as a fruitful avenue for further study.

Entities:  

Mesh:

Year:  2011        PMID: 21776790     DOI: 10.1118/1.3577602

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm.

Authors:  Ruediger P Laubender; Julia Lynghjem; Melvin D'Anastasi; Volker Heinemann; Dominik P Modest; Ulrich R Mansmann; Ute Sartorius; Michael Schlichting; Anno Graser
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

2.  Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma.

Authors:  Jessemae L Welsh; Kellie Bodeker; Elizabeth Fallon; Sundershan K Bhatia; John M Buatti; Joseph J Cullen
Journal:  Am J Surg       Date:  2012-08-14       Impact factor: 2.565

3.  Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.

Authors:  Lu Xu; Xin-Hua Xu; Cheng Yuan; Jia-Yu Zhang; Xi Tang; Dian Chen; Xiao-Long Wang; Guang Zeng
Journal:  Ann Transl Med       Date:  2018-10

4.  RECIST Applied to Realistic Tumor Models.

Authors:  Zachary H Levine; Benjamin R Galloway; Adele P Peskin
Journal:  J Res Natl Inst Stand Technol       Date:  2011-06-01

5.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Authors:  Maliha Sadick; Stefan O Schoenberg; Karl Hoermann; Haneen Sadick
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.